Bidirectional dual causality found between psoriasis and Crohn's disease in new study Niveditha Subramani12 Jan 2023 10:00 AM ISTA recent study, published in Scientific reports journal summarizes statistics from Mendelian Randomization (MR) analysis and says study strengthens...
Mirikizumab efficacy to placebo for treating moderate-to-severe plaque psoriasis Medha Baranwal3 Jan 2023 8:00 PM ISTUSA: Interleukin (IL)-23 and IL-17 are known to play critical roles in the development of psoriatic disease, so therapies targeting these cytokines...
People with autoimmune disease more likely to develop cardiac complications after MI Dr. Kamal Kant Kohli26 Dec 2022 8:00 PM ISTAutoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosis and psoriasis, are known to increase risk of cardiovascular disease,...
Dr Reddy's Labs arm Aurigene reports results of AUR101 in Phase II study in patients with moderate to severe psoriasis Ruchika Sharma16 Dec 2022 12:25 PM ISTAUR-101 is a potent, oral RORÏ’t inverse agonist, with high selectivity across other ROR isoforms and nuclear hormone receptors and expected to confer...
Takeda to acquire Oral Allosteric TYK2 Inhibitor NDI-034858 from Nimbus Therapeutics Ruchika Sharma14 Dec 2022 11:01 AM ISTJapan: Takeda has announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is an oral, selective allosteric...
Inflammatory bowel disease associated with chronic inflammatory skin diseases Dr.Niharika Harsha B9 Dec 2022 8:00 PM ISTA new study revealed that inflammatory bowel disease was associated with various chronic inflammatory skin diseases. IBD incidence was increased in...
PCSK9 inhibitors may lower risk of developing Psoriasis: JAMA. Dr.Niharika Harsha B8 Dec 2022 7:45 PM ISTA new 2-sample mendelian randomization study found genetic evidence that proprotein convertase subtilisin/kexin type 9 is involved in the pathogenesis...
Herpes patients at higher risk of Psoriasis, states cohort study Aditi5 Dec 2022 8:00 PM ISTTaiwan: A recent study published in the Australasian Journal of Dermatology has demonstrated an increased risk of Psoriasis in patients diagnosed with...
Patients undergoing ixekizumab therapy for moderate-to-severe psoriasis shows strong adherence Jacinthlyn Sylvia4 Dec 2022 8:00 PM ISTBiologic-naive patients with moderate-to-severe psoriasis (PsO) who were treated with ixekizumab demonstrated greater adherence and continued the...
Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara Ruchika Sharma1 Dec 2022 1:15 PM ISTIf Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.
Oral probiotics and topical hydrocortisone may reduce severity of Psoriasis Jacinthlyn Sylvia27 Nov 2022 8:00 PM ISTPsoriasis area severity index (PASI), Dermatology life quality index (DLQI), and visual analogue scale (VAS) was improved in psoriasis patients who...
Psoriasis does not increase MI risk among patients with end stage renal disease Jacinthlyn Sylvia8 Nov 2022 8:00 PM ISTA new study published in The American Journal of the Medical Sciences shows that psoriasis was not linked to an elevated risk of myocardial infarction...
